Researchers used a decision tree model combining clinical effectiveness, utility and cost data. They conducted sensitivity analyses to determine the robustness of the model outcomes.
The oral probiotics strategy offered patients 0.05876 quality-adjusted life years, and the no probiotics strategy offered 0.056 quality-adjusted life years. The cost of the oral probiotics strategy was $16,668.70, while the no probiotics strategy was $20,355.28.
“The oral probiotics strategy exhibited higher QALY and lower cost, and represents the cost-saving strategy,” study authors wrote.
More articles on healthcare quality:
Staffing issues force Denver hospital to suspend transplant program: 7 things to know
Man sues South Carolina hospital for allegedly leaving surgical glove inside him after surgery
Joint Commission denies Baltimore hospital preliminary accreditation over issues with dialysis center
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
